Incannex Healthcare Inc.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Emerging growth company
State of Incorporation
DE
Country
Australia
Business Address
8 CENTURY CIRCUIT, NORWEST NSW, ,
Mailing Address
8 CENTURY CIRCUIT, NORWEST NSW, ,
Phone
61 409 840 786
Fiscal Year End
0630
EIN
000000000
Financial Overview
FY2025
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 8-K Current report of material events | March 27, 2026 | View on SEC |
| 8-K Current report of material events | March 25, 2026 | View on SEC |
| 8-K Current report of material events | March 18, 2026 | View on SEC |
| 8-K Current report of material events | March 17, 2026 | View on SEC |
| 424B5 Prospectus supplement | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 8-K Current report of material events | March 12, 2026 | View on SEC |
| 8-K Current report of material events | February 25, 2026 | View on SEC |
| 10-Q Quarterly financial report | February 13, 2026 | View on SEC |
| 8-K Current report of material events | January 29, 2026 | View on SEC |
Annual Reports
10-K
September 29, 2025
- Advanced clinical trials including Phase 3 for sleep apnea treatment
- Partnered with a top research university to boost credibility
Material Events
8-K
Strategy Change
March 17, 2026
High Impact
- Incannex Healthcare Inc. has regained full compliance with Nasdaq's listing requirements, ensuring its continued listing on the Nasdaq Capital Market.
- The company implemented a 1-for-10 reverse stock split to meet the minimum bid price requirement, removing the immediate threat of delisting.
8-K
Strategy Change
February 25, 2026
High Impact
- Incannex Healthcare Inc. will implement a 1-for-30 reverse stock split to consolidate shares.
- The primary goal is to regain and maintain compliance with Nasdaq's minimum bid price requirement of $1.00 per share.
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.